Use of sonographic markers to determine the risk of Down syndrome in second-trimester fetuses., Radiology, vol.201, issue.3, pp.619-620, 1996. ,
DOI : 10.1148/radiology.201.3.8939206
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation, BJOG: An International Journal of Obstetrics and Gynaecology, vol.305, issue.12, pp.957-962, 1995. ,
DOI : 10.1016/S0140-6736(86)91218-3
An association between low maternal serum ??-fetoprotein and fetal chromosomal abnormalities, American Journal of Obstetrics and Gynecology, vol.148, issue.7, pp.886-894, 1984. ,
DOI : 10.1016/0002-9378(84)90530-1
Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenatal Diagnosis, vol.98, issue.9, pp.623-630, 1987. ,
DOI : 10.1002/pd.1970070904
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome, BJOG: An International Journal of Obstetrics and Gynaecology, vol.26, issue.4, pp.334-341, 1988. ,
DOI : 10.1016/S0140-6736(84)92389-4
Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second Trimesters, New England Journal of Medicine, vol.341, issue.7, pp.461-467, 1999. ,
DOI : 10.1056/NEJM199908123410701
1993 Regulation of chorionic gonadotropin gene expression, Endocr Rev, vol.14, pp.203-221 ,
The physiology of placental lactogen in human pregnancy, Endocrinol, vol.12, pp.329-336, 1991. ,
Human placental growth hormone, American Journal of Obstetrics and Gynecology, vol.177, issue.6, pp.1526-1534 ,
DOI : 10.1016/S0002-9378(97)70103-0